Understanding Your Pathology & Lab Reports
At a Glance
An IgG4-RPF diagnosis relies on a tissue biopsy showing three key features: dense immune cells, storiform fibrosis, and obliterated veins. Pathologists also look for high IgG4+ plasma cell counts and a ratio over 40%. Blood IgG4 levels are often normal, making the tissue biopsy crucial.
When you receive your pathology and lab reports, the language can seem like a different dialect. For IgG4-related retroperitoneal fibrosis (IgG4-RPF), the diagnosis isn’t based on one single “positive” or “negative” result. Instead, doctors look for a specific pattern of findings in your tissue and blood.
The Pathology “Triad”
Pathologists look for three main microscopic features to confirm IgG4-RD. This is often called the “histopathologic triad”:
- Dense Lymphoplasmacytic Infiltrate: This simply means the tissue is packed with a high number of lymphocytes and plasma cells (types of white blood cells) [1][2].
- Storiform Fibrosis: This is a very specific type of scarring. “Storiform” comes from the Latin word for a woven mat. Under a microscope, the scar tissue looks like it has been woven together in a circular or “wagon-wheel” pattern [1][3].
- Obliterative Phlebitis: This occurs when the inflammatory cells and scar tissue squeeze small veins until they are completely closed or “obliterated” [1][4].
The “Fingerprint”: IgG4+ Plasma Cells
To confirm the disease is specifically IgG4-related, the pathologist uses a special stain called immunohistochemistry (IHC) to count the IgG4-positive plasma cells [3][5].
- The Count: In the retroperitoneum, doctors typically look for at least 10 IgG4+ plasma cells per “high-power field” (the area visible under the microscope at high magnification) [6].
- The Ratio: They also calculate the IgG4+/IgG+ ratio. If more than 40% of the total plasma cells in the tissue are producing IgG4, it strongly supports the diagnosis [6][6].
Why Your Blood Work Might Be Normal
You might be surprised to find your serum IgG4 (the level of IgG4 in your blood) is within the normal range, even after a biopsy confirms the disease.
- Serum vs. Tissue: About 30% to 50% of people with biopsy-proven IgG4-RD have normal serum IgG4 levels [7][8]. The disease can be very active in your organs even if it doesn’t “spill over” into your bloodstream in large amounts [7][9].
- Monitoring: Because of this, a normal blood test doesn’t mean you are in the clear. Doctors will rely more on your symptoms and imaging (like CT or MRI scans) to track your progress [9][10].
Pathology Report Completeness Checklist
When reviewing your pathology report, check for these specific data points. If they are missing, you may want to ask if the pathologist can provide them:
- [ ] IgG4+ cell count (e.g., “X cells per HPF”) [6].
- [ ] IgG4+/IgG+ ratio (e.g., “>40%”) [6].
- [ ] Mention of storiform fibrosis [1].
- [ ] Mention of obliterative phlebitis [1].
- [ ] Exclusion of malignancy: A statement that no cancer cells (like lymphoma) were seen [11][12].
Note: If you were taking steroids before your biopsy, the cell counts might appear lower than they actually are, as these medications quickly clear immune cells from the tissue [13].
Common questions in this guide
What is the histopathologic triad in an IgG4-RPF biopsy?
Why is my blood IgG4 normal if my biopsy shows IgG4-RPF?
What IgG4 cell count is needed to confirm the diagnosis?
How do steroids affect my IgG4-RPF biopsy results?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What was the exact IgG4+ plasma cell count per high-power field (HPF) in my sample?
- 2.What was the IgG4+/IgG+ ratio reported in the biopsy?
- 3.Did the pathologist find evidence of storiform fibrosis or obliterative phlebitis?
- 4.If my serum IgG4 levels are normal, how does that affect our monitoring plan?
- 5.Does the presence of 'dense fibrosis' in my report make it harder to confirm the IgG4-RD diagnosis?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (13)
- 1
The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease.
Wallace ZS, Naden RP, Chari S, et al.
Arthritis & rheumatology (Hoboken, N.J.) 2020; (72(1)):7-19 doi:10.1002/art.41120.
PMID: 31793250 - 2
IgG4-related Disease Affecting Multiple Organs Despite Normal Serum IgG4 Levels.
Kida T, Watanabe K, Nishikawa M, et al.
Internal medicine (Tokyo, Japan) 2026; doi:10.2169/internalmedicine.7062-25.
PMID: 42178251 - 3
IgG4-related disease in patients with newly diagnosed idiopathic retroperitoneal fibrosis: a population-based Danish study.
Lomborg N, Jakobsen M, Bode CS, Junker P
Scandinavian journal of rheumatology 2019; (48(4)):320-325 doi:10.1080/03009742.2018.1551963.
PMID: 30931680 - 4
IgG4-related retroperitoneal fibrosis: A case report of a challenging disease.
Farook S, Jilani MSA, Islam MK, et al.
Clinical case reports 2023; (11(9)):e7865 doi:10.1002/ccr3.7865.
PMID: 37663821 - 5
Differential Diagnosis: Retroperitoneal Fibrosis and Oncological Diseases.
Sica A, Casale B, Spada A, et al.
Open medicine (Warsaw, Poland) 2018; (15()):22-26 doi:10.1515/med-2020-0005.
PMID: 31922016 - 6
Retrospective single-centre analysis of IgG4-related disease patient population and treatment outcomes between 2007 and 2017.
Lee CM, Alalwani M, Prayson RA, Gota CE
Rheumatology advances in practice 2019; (3(1)):rkz014 doi:10.1093/rap/rkz014.
PMID: 31432002 - 7
Case report: IgG4-related renal disease co-existing with retroperitoneal fibrosis.
Kim YJ, Kim GE, Ma SK, et al.
Translational andrology and urology 2020; (9(2)):794-799 doi:10.21037/tau.2020.02.06.
PMID: 32420186 - 8
Clinicopathological characteristics of IgG4-related lung disease.
Liu J, Liu Y, Shen X, et al.
BMC pulmonary medicine 2021; (21(1)):413 doi:10.1186/s12890-021-01781-3.
PMID: 34911521 - 9
Clinicopathological features of type 1 autoimmune pancreatitis without elevated serum IgG4 level.
Yamashita Y, Ishii Y, Hanada K, et al.
Scientific reports 2025; (15(1)):24518 doi:10.1038/s41598-025-10478-0.
PMID: 40628889 - 10
A case of IgG4-related kidney disease with predominantly unilateral renal atrophy.
Takeji A, Yamada K, Inoue D, et al.
CEN case reports 2019; (8(1)):8-13 doi:10.1007/s13730-018-0355-9.
PMID: 30062635 - 11
Clinicopathological Pearls and Diagnostic Pitfalls in IgG4-Related Disease: Challenging Case Series and Literature Review.
Sina S, Bonisoli GL, Vitale S, et al.
Diagnostics (Basel, Switzerland) 2025; (15(18)) doi:10.3390/diagnostics15182299.
PMID: 41008670 - 12
IgG4-related disease mimicking renal pelvis tumor with peritoneal carcinomatosis.
Chang CW, Tang SH, Su CH, et al.
Clinical case reports 2020; (8(10)):2040-2045 doi:10.1002/ccr3.3063.
PMID: 33088547 - 13
IgG4-related disease: an analysis of the clinicopathological spectrum: UK centre experience.
Dassanayaka W, Liyanaarachchi KS, Ala A, Bagwan IN
Journal of clinical pathology 2023; (76(1)):53-58 doi:10.1136/jclinpath-2021-207748.
PMID: 34413088
This page explains IgG4-RPF pathology terminology for educational purposes only. Your pathologist and treating physician are the best sources for interpreting your specific biopsy and blood test results.
Get notified when new evidence is published on IgG4-related retroperitoneal fibrosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.